Prostate cancer: open trials in New Zealand

10 open trials have a site in New Zealand. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Dunedin Hospital-Southern Blood and Cancers Service (Site 1203), Dunedin · Tauranga Hospital-Bay of Plenty Clinical Trials Unit (Site 1201), Tauranga
Registry updated 2026-11-05
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Auckland City Hospital, Auckland · Christchurch Hospital, Christchurch · Waikato Hospital, Hamilton · Tauranga Hospital, Tauranga · Imed Radiology, Tauranga
Registry updated 2026-10-30
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Palmerstone North Hospital, Roslyn · Health New Zealand, Wellington
Registry updated 2026-10-30
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Auckland City Hospital (Site 1033), Auckland · Dunedin Hospital (Site 1032), Dunedin
Registry updated 2026-10-20
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Auckland City Hospital, Auckland · Christchurch Hospital, Christchurch · Waikato Hospital, Hamilton · Palmerston North Hospital, Palmerston North · Tauranga Hospital, Tauranga
Registry updated 2026-10-14
NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Auckland City Hospital (Site 0831), Auckland
Registry updated 2026-10-09
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Grafton · Hamilton
Registry updated 2026-10-01
NCT06520345
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Trial Treatment · Phase 3 · Telix Pharmaceuticals (Innovations) Pty Limited
New Zealand Clinical Research - Christchurch, Christchurch · Auckland City Hospital, Grafton
Registry updated 2026-07-21
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
Trial Treatment · Gabriela Ilie
Prostate Cancer Foundation of New Zealand, Auckland
Registry updated 2026-03-18
NCT05613023
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
Trial Treatment · Phase 3 · Institute of Cancer Research, United Kingdom
Auckland Hospital, Auckland
Registry updated 2024-09-19

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error